NEUROSENSE THERAPEUTICS LTD (NRSN) Stock Analyst Ratings
NASDAQ:NRSN - Nasdaq - IL0011809592 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to NRSN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.97. This target is 480.16% above the current price.
NRSN was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NRSN.
In the previous month the buy percentage consensus was at a similar level.
NRSN was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-12 | D. Boral Capital | Initiate | Buy |
| 2024-12-16 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-07-17 | Alliance Global Partners | Initiate | Buy |
| 2022-01-07 | Maxim Group | Initiate | Buy |